Issue 9, 2024

Polydopamine modified by pillar[5]arene in situ for targeted chemo-photothermal cancer therapy

Abstract

A pillar[5]arene-modified polydopamine (PDA-P[5]OH) displaying pH/NIR dual-responsive properties was constructed successfully in situ for targeted chemo-photothermal cancer therapy.

Graphical abstract: Polydopamine modified by pillar[5]arene in situ for targeted chemo-photothermal cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
14 Sep 2023
Accepted
11 Dec 2023
First published
12 Dec 2023

Chem. Commun., 2024,60, 1160-1163

Polydopamine modified by pillar[5]arene in situ for targeted chemo-photothermal cancer therapy

R. Tang, L. Zhou, Y. Dai, Y. Wang, Y. Cai, T. Chen and Y. Yao, Chem. Commun., 2024, 60, 1160 DOI: 10.1039/D3CC04196D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements